Staar Surgical (STAA) FY2016 results: revenue $82 million, up 6.9% on the year
Staar Surgical Co. (STAA) reported revenue of $82 million for fiscal 2016, the year ended 30 December 2016, up 6.9% on the year before. Net income was -$12 million, and diluted earnings per share $-0.30. The figures are the company's own, from the 10-K it filed with the SEC on 21 February 2019.
Revenue
$82 million
+6.9% on the year
FY2009FY2016
Operating margin
-15.4%
-6.9% a year earlier
FY2009FY2016
Net income
-$12 million
FY2009FY2016
Diluted EPS
-$0.30
FY2009FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
82.4
77.1
75.0
+6.9%
Cost of revenue
24.1
24.4
26.2
-1.4%
Gross profit
58.4
52.7
48.8
+10.7%
Gross margin
70.8%
68.4%
65.1%
Research and development
20.7
14.8
12.4
+40.0%
Selling, general and administrative
71.0
n/a
n/a
Operating income
-12.7
-5.3
-8.0
Operating margin
-15.4%
-6.9%
-10.7%
Interest expense
0.1
0.1
0.2
+43.6%
Pre-tax income
-12.4
-5.6
-8.6
Income tax
-0.3
0.9
-0.3
Net income
-12.1
-6.5
-8.4
Net margin
-14.7%
-8.5%
-11.2%
Diluted EPS
-$0.30
-$0.17
-$0.22
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
1.0
-2.2
-8.0
Capital expenditure
3.2
2.0
4.1
+56.7%
Free cash flow
-2.2
-4.2
-12.0
Free cash flow margin
-2.6%
-5.5%
-16.0%
Cash from investing
-3.2
-2.0
n/a
Cash from financing
3.0
4.6
n/a
-35.5%
Depreciation and amortisation
2.9
2.4
2.5
+20.4%
Share-based compensation
8.6
3.3
4.7
+159.0%
Diluted shares, weighted
40m
39m
38m
+2.7%
Shares outstanding at period end
41m
40m
38m
+2.1%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
37.9
38.8
37.1
-2.4%
Debt
4.3
4.2
4.2
+3.0%
Other liabilities
23.3
19.9
17.7
+16.6%
Total liabilities and equity
65.4
63.0
58.9
+4.0%
Fixed assets
11.8
10.1
10.1
+16.8%
Goodwill
1.8
1.8
1.8
0.0%
Intangible assets
0.5
0.7
0.9
-29.0%
Cash and equivalents
14.0
13.4
13.0
+4.5%
Receivables
16.3
15.7
11.1
+4.3%
Inventory
n/a
15.9
15.7
Other assets
21.1
5.4
6.4
+289.2%
Total assets
65.4
63.0
58.9
+4.0%
10-K for the year ended 30 December 2016, filed 21 February 2019: the filing.